Industry Connect with CSL

UQ researchers are cordially invited to join an online information session to hear
Dr Marthe D’Ombrain of CSL launch their 2021 Research Acceleration Initiative.

CSL’s Research Acceleration Initiative aims to fast-track discovery of innovative biotherapies through partnerships between CSL and UQ, and other Australian and global research organisations.

Applications open 4 January 2021. Successful applicants will receive up to $250,000 per year for up to 2 years (max $500,000 funding) to accelerate translation of their research.

The initiative focuses on projects that have potential to impact therapies for patients in CSL’s strategic focus, which is the intersection of the therapeutic areas, focus areas and modalities of interest below. Download CSL flyer for more detailed information on below areas.

Therapeutic areas

Immunology
Hematology
Respiratory
Cardiovascular and Metabolic
Transplant

Focus areas

Novel drug targets
Novel therapeutic candidates
Novel strategies for treating disease

Modalities

Antibodies
Recombinant proteins
Cell and gene therapies
Small molecules NOT of interest

Next steps

Download application form

Join online information sessions as listed below in February

Completed applications to csl@uniquest.com.au by Friday, 5 March 2021

Online information session details

Time

1:00pm - 2:00pm (Brisbane time)

11:00am - 12:00pm (Brisbane time)

Date

Tuesday, 9 February 2021

Friday, 12 February 2021

Online session links

For online session links please email

csl@uniquest.com.au

Contact us

Contact us for more information about this and other Industry Connect events.

Contact us